We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+13.47%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$125B
AUM Growth
+$16.6B
(+15%)
Cap. Flow
+$5.87B
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
1,656
New
55
Increased
780
Reduced
193
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$505M |
| 2 |
Apple
AAPL
|
+$375M |
| 3 |
NVIDIA
NVDA
|
+$370M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$339M |
| 5 |
Zoetis
ZTS
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$391M |
| 2 |
Becton Dickinson
BDX
|
+$373M |
| 3 |
Revvity
RVTY
|
+$303M |
| 4 |
HOLX
Hologic
HOLX
|
+$242M |
| 5 |
IQVIA
IQV
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.35% |
| 2 | Financials | 15.52% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Healthcare | 9.37% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
BioNTech
BNTX
$23.4B
| $247K | ﹤0.01% |
2,321
-173
| -7% | -$17.5K |
|
952
Krystal Biotech
KRYS
$9.83B
| $247K | ﹤0.01% |
1,795
+303
| +20% | +$44.5K |
|
953
Ultragenyx Pharmaceutical
RARE
$2.62B
| $247K | ﹤0.01% |
6,783
+441
| +7% | +$15.9K |
|
|
LX
954
LexinFintech Holdings
LX
$239M
| $244K | ﹤0.01% |
33,910
-12,296
| -27% | -$95.4K |
|
955
Blue Owl Capital
OWL
$18.9B
| $240K | ﹤0.01% |
12,469
-37,419
| -75% | -$692K |
|
956
Wave Life Sciences
WVE
$1.05B
| $235K | ﹤0.01% |
36,097
+17,424
| +93% | +$115K |
|
|
KEEL
957
Keel Infrastructure Corp
KEEL
$2.26B
| $233K | ﹤0.01% |
277,853
+144,593
| +109% | +$134K |
|
958
Repay Holdings
RPAY
$306M
| $233K | ﹤0.01% |
48,330
+20,417
| +73% | +$93.2K |
|
959
Arrowhead Research
ARWR
$12.6B
| $232K | ﹤0.01% |
14,702
+226
| +2% | +$3.24K |
|
960
Paymentus
PAY
$5.03B
| $231K | ﹤0.01% |
7,061
-1,141
| -14% | -$38.2K |
|
961
Euronet Worldwide
EEFT
$2.59B
| $231K | ﹤0.01% |
2,278
-421
| -16% | -$43.5K |
|
962
Xencor
XNCR
$1.71B
| $231K | ﹤0.01% |
29,371
+17,773
| +153% | +$160K |
|
963
Immersion
IMMR
$245M
| $229K | ﹤0.01% |
29,054
-36,823
| -56% | -$274K |
|
964
Arbutus Biopharma
ABUS
$899M
| $227K | ﹤0.01% |
73,543
-2,488
| -3% | -$8.26K |
|
965
Beam Therapeutics
BEAM
$2.79B
| $226K | ﹤0.01% |
13,300
+2,808
| +27% | +$48.9K |
|
|
HIVE
966
HIVE Digital Technologies
HIVE
$742M
| $224K | ﹤0.01% |
124,450
+55,141
| +80% | +$97.2K |
|
|
CLDT
967
Chatham Lodging
CLDT
$581M
| $217K | ﹤0.01% |
31,108
| – | – |
|
968
uniQure
QURE
$3.13B
| $215K | ﹤0.01% |
+15,420
| New | +$207K |
|
969
Paysafe
PSFE
$346M
| $215K | ﹤0.01% |
17,026
+4,711
| +38% | +$64.4K |
|
970
Ionis Pharmaceuticals
IONS
$9.4B
| $213K | ﹤0.01% |
5,398
-737
| -12% | -$24.1K |
|
971
Deluxe
DLX
$1.09B
| $213K | ﹤0.01% |
13,378
+5,504
| +70% | +$82.9K |
|
972
Iovance Biotherapeutics
IOVA
$2.98B
| $213K | ﹤0.01% |
123,598
+91,199
| +281% | +$227K |
|
|
RNAM
973
DELISTED
Avidity Biosciences
RNAM
| $212K | ﹤0.01% |
7,461
+1,326
| +22% | +$39.5K |
|
974
Forum Energy Technologies
FET
$926M
| $208K | ﹤0.01% |
+10,673
| New | +$173K |
|
975
Bitdeer Technologies
BTDR
$2.48B
| $207K | ﹤0.01% |
+17,997
| New | +$208K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Mitsubishi UFJ Asset Management held 1,656 positions worth $125B, up 15% from $109B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Mitsubishi UFJ Asset Management deployed $5.87B of net new capital in Q2 2025, opening 55 new positions and adding to 780 existing holdings. Its largest new stake was JPMorgan Global Select Equity ETF: 210,973 shares worth $13.6M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $391M trimmed.
- Mitsubishi UFJ Asset Management's largest Q2 2025 buy was JPMorgan Global Select Equity ETF: 210,973 shares worth $13.6M.
- Mitsubishi UFJ Asset Management added most to Microsoft in Q2 2025, an estimated $505M increase.
- Mitsubishi UFJ Asset Management's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $391M.
- Mitsubishi UFJ Asset Management fully exited Discover Financial Services in Q2 2025, selling an estimated $76.4M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 33% of its $125B portfolio in Q2 2025.
- Mitsubishi UFJ Asset Management opened 55 new positions and closed 41 in Q2 2025.
- Mitsubishi UFJ Asset Management's portfolio value rose 15% quarter-over-quarter to $125B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.